BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 23165333)

  • 1. Evaluation of SF-1 expression in testicular germ cell tumors: a tissue microarray study of 127 cases.
    Sangoi AR; McKenney JK; Brooks JD; Higgins JP
    Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):318-21. PubMed ID: 23165333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the RNA component of human telomerase in adult testicular germ cell neoplasia.
    Delgado R; Rathi A; Albores-Saavedra J; Gazdar AF
    Cancer; 1999 Nov; 86(9):1802-11. PubMed ID: 10547554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma.
    Jones TD; Ulbright TM; Eble JN; Baldridge LA; Cheng L
    Am J Surg Pathol; 2004 Jul; 28(7):935-40. PubMed ID: 15223965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SALL4 is a novel diagnostic marker for testicular germ cell tumors.
    Cao D; Li J; Guo CC; Allan RW; Humphrey PA
    Am J Surg Pathol; 2009 Jul; 33(7):1065-77. PubMed ID: 19390421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas.
    Gopalan A; Dhall D; Olgac S; Fine SW; Korkola JE; Houldsworth J; Chaganti RS; Bosl GJ; Reuter VE; Tickoo SK
    Mod Pathol; 2009 Aug; 22(8):1066-74. PubMed ID: 19396148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testicular Tumors: A Contemporary Update on Morphologic, Immunohistochemical and Molecular Features.
    Al-Obaidy KI; Idrees MT
    Adv Anat Pathol; 2021 Jul; 28(4):258-275. PubMed ID: 33871428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt suppressor and stem cell regulator TCF7L1 is a sensitive immunohistochemical marker to differentiate testicular seminoma from non-seminomatous germ cell tumor.
    Bu L; Yang Q; McMahon L; Xiao GQ; Li F
    Exp Mol Pathol; 2019 Oct; 110():104293. PubMed ID: 31381875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testicular tumors--some new and a few perennial problems.
    Young RH
    Arch Pathol Lab Med; 2008 Apr; 132(4):548-64. PubMed ID: 18384207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-binding protein LIN28 is a marker for testicular germ cell tumors.
    Cao D; Allan RW; Cheng L; Peng Y; Guo CC; Dahiya N; Akhi S; Li J
    Hum Pathol; 2011 May; 42(5):710-8. PubMed ID: 21288558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of p63 in testicular germ cell neoplasia.
    Emanuel PO; Unger PD; Burstein DE
    Ann Diagn Pathol; 2006 Oct; 10(5):269-73. PubMed ID: 16979518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCL1 protein expression in testicular germ cell tumors.
    Lau SK; Weiss LM; Chu PG
    Am J Clin Pathol; 2010 May; 133(5):762-6. PubMed ID: 20395523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Transcription Factors and Nuclear Receptors in Mixed Germ Cell-Sex Cord Stromal Tumor and Related Tumors of the Gonads.
    Roth LM; Cheng L
    Int J Gynecol Pathol; 2015 Nov; 34(6):528-34. PubMed ID: 26107563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases.
    Sangoi AR; Karamchandani J; Lane B; Higgins JP; Rouse RV; Brooks JD; McKenney JK
    Mod Pathol; 2011 Mar; 24(3):425-9. PubMed ID: 21102418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein overexpression and gene amplification of epidermal growth factor receptor in adult testicular germ cell tumors: potential role in tumor progression.
    Miyai K; Yamamoto S; Asano T; Tamai S; Matsubara O; Tsuda H
    Cancer Sci; 2010 Sep; 101(9):1970-6. PubMed ID: 20608935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDX-2 expression in malignant germ cell tumors of the testes, intratubular germ cell neoplasia, and normal seminiferous tubules.
    Lee MJ; Vogt AP; Hsiao W; Osunkoya AO
    Tumour Biol; 2012 Dec; 33(6):2185-8. PubMed ID: 22895825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glypican 3: a novel marker in testicular germ cell tumors.
    Zynger DL; Dimov ND; Luan C; Teh BT; Yang XJ
    Am J Surg Pathol; 2006 Dec; 30(12):1570-5. PubMed ID: 17122513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of 2 testicular germ cell markers, Glut3 and CyclinA2.
    Howitt BE; Brooks JD; Jones S; Higgins JP
    Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):401-7. PubMed ID: 23343953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on testicular sex cord-stromal tumors and those composed of both germ cells and sex cord-stromal derivatives with a comparison to corresponding ovarian neoplasms.
    Roth LM; Lyu B; Cheng L
    Hum Pathol; 2017 Jul; 65():1-14. PubMed ID: 28445692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibin-alpha CD99, HEA125, PLAP, and chromogranin immunoreactivity in testicular neoplasms and the androgen insensitivity syndrome.
    Kommoss F; Oliva E; Bittinger F; Kirkpatrick CJ; Amin MB; Bhan AK; Young RH; Scully RE
    Hum Pathol; 2000 Sep; 31(9):1055-61. PubMed ID: 11014571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.